Back to search

Article

hENT Inhibition Prevents Pyrimidine-Driven Resistance to DHODH Inhibition in Malignant Rhabdoid Tumors

2026-01-27

Abstract excerpt

Extracranial malignant rhabdoid tumors (ecMRTs) are aggressive pediatric cancers characterized by mutations in genes encoding members of the SWItch/Sucrose Non-Fermentable (SWI/SNF) chromatin remodeling complex, with limited effective treatment options. Metabolic reprogramming, including nucleotide biosynthesis, is a hallmark of cancer that represents a potential therapeutic vulnerability. Previously, we demonstra...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
846d5456-a8d4-513b-8560-e6c6b93c41b0
DOI
10.64898/2026.01.25.701565
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
hENT Inhibition Prevents Pyrimidine-Driven Resistance to DHODH Inhibition in Malignant Rhabdoid TumorsDOI 10.64898/2026.01.25.701565
Select a neighboring publication to make it the new centre.